A Study on the Safety and Efficacy of BST08 in Treating Advanced Non-Small Cell Lung Cancer

Summary

This study is an exploratory clinical trial initiated by an open, single arm researcher to evaluate the safety, tolerability, and preliminary efficacy of BST08 in the treatment of advanced non-small cell lung cancer in subjects. This study plans to set up two experimental groups: monotherapy group A: 9x10 \^ 10 BST08 (3 cases) and combination therapy group B: 9x10 \^ 10 BST08+Pabolizhu 200mg Q3W (6 cases).

Timeline

Start

2024-10-24

Primary completion

2026-08-31

Completion

2027-08-31

Drugs

Indications